Paraoxonase and HDL Qualities in Glycaemia and Inflammation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Paraoxonase and HDL Qualities in Glycaemia and Inflammation — Stella

Recruiting

Back to Diabetes Mellitus trials

Trial locations(1 site)

United Kingdom

Central Manchester University Hospitals NHS Foundatioon Trust, Manchester, Lancashire

Key details

Sponsor

Manchester University NHS Foundation Trust

Collaborators

British Heart Foundation, Juvenile Diabetes Research Foundation

Enrollment target

~600 participants

Started

July 2012

Primary completion

January 2030

Age range

20 Years – 75 Years

Last updated April 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov